RenalGuard Therapy Gets Breakthrough Device Designation for Prevention of Cardiac Surgery Associated AKI
The FDA granted Breakthrough Device Designation for CardioRenal Systems' RenalGuard Therapy device for the prevention of acute kidney injury.
The FDA granted Breakthrough Device Designation for CardioRenal Systems' RenalGuard Therapy device for the prevention of acute kidney injury.
The U.S. FDA is alerting healthcare providers about potential malfunctions with MitraClip Clip Delivery Systems manufactured by Abbott.
The Medtronic Heartware Ventricular Assist Device (HVAD) System may have a welding defect in the internal pump causing a malfunction.
The FDA granted Breakthrough Device Designation for CardioRenal Systems' RenalGuard Therapy device for the prevention of acute kidney injury.
Royal Philips has unveiled a full-service, at-home, 12-lead electrocardiogram (ECG) solution for use in decentralized clinical trials.
Read MoreAbbott has received FDA clearance for a new cardiac mapping platform that is designed to help physicians better treat abnormal heart rhythm.
Read MoreApproximately 70% of out-of-hospital cardiac arrests occur in private homes that don’t have an automated external defibrillator.
Read MoreBoth new electrocardiography devices offer up-to-date orders lists, continuous connectivity, and patient data query.
Read MoreSome major factors that have boosted the market growth include a rise in incidence of sudden cardiac arrest.
Read MoreThe government alleges that St. Jude failed to disclose serious adverse health events in connection with the premature depletion of the battery in certain models of its implantable defibrillators.
Read MoreVitalPatch RTM mobile cardiac telemetry solution allows for continuous, real-time cardiac arrhythmia detection while simultaneously measuring patient physiological parameters.